Dr. Sun co-founded Genome Opinion and leads technology development activities and bio-informatics function of the Company. Previously, Dr. Sun worked as principal researcher & engineer at Genome Analytics group of Samsung SDS.



  • PhD, Computer Science, KAIST (Korea Advanced Institute of Science and Technology)



  • 20+ publications (Nature Communications, Hematologica, Genetics in Medicine, etc.)
  • Clonal hematopoiesis is associated with risk of severe Covid-19, Nature Reviews, 2021
  • MED-TMA: A clinical decision support tool for differential diagnosis of TMA with enhanced accuracy using an ensemble method, Thrombosis Research, 2020

Choonghyun Sun, PHD

Co-Founder, Chief Technology Officer